To actively promote the construction of a regionally coordinated and efficient nuclear medicine technology innovation system, and to enhance the construction level of nuclear medicine departments and the capabilities of nuclear medicine researchers in Sichuan Province, on December 20th, the "Setting Off Anew, Leading the Future with Nuclear Medicine —— Nuclear Medicine Technology Innovation and Technology Transfer Capacity Enhancement Class" was successfully held in Chengdu. This event was guided by the Health Commission of Sichuan Province and the Sichuan Provincial Drug Administration, and was organized by the Sichuan Medical Science and Education Center, the Western Sichuan Medical Technology Transfer Center, and the Sichuan Pharmaceutical Industry Association.

Attending the meeting and delivering speeches were Cao Li, Deputy Inspector of the Health Commission of Sichuan Province, Li Hua, Deputy Director of the Sichuan Provincial Drug Administration, and representatives from the Industrial Promotion Department of the Sichuan Provincial Military-Civil Fusion Office. Also present were Zhang Fanrong, Director of the Department of Science and Education, Cao Hua, Director of the Department of System Reform and Policy Research, Li Xu, Director of the Department of Pharmaceutical and Food, Liu Cheng, Director of the Department of International Cooperation, Qiu Zan, Director of the Center for Aging Health, and Zhao Ziling, Deputy Director of the Sichuan Medical Science and Education Center. The opening ceremony was presided over by Bi Mingzhao, Director of the Sichuan Medical Science and Education Center.

He Xintan, General Manager of Zhongjiu Flashlight Company, was invited to give a keynote speech on Flash radiotherapy technology.

At the Nuclear Medicine Technology Innovation and Technology Transfer Capacity Enhancement Class

Cao Li emphasized that Sichuan has superior material resources and strong support in scientific research, education, and medical care in the field of nuclear medicine, providing a solid foundation for industrial development. She advocated that medical institutions should strengthen the construction of nuclear medicine departments, deepen technological cooperation with pharmaceutical companies, seize new opportunities, and promote scientific research breakthroughs to improve public health through innovative results and products.

Speech by Cao Li, Deputy Inspector of the Health Commission of Sichuan Province

Li Hua highlighted Sichuan's unique advantages in the nuclear medicine industry, mentioning that multiple projects are being actively promoted with vibrant technological innovation and technology transfer. The provincial drug administration will support industrial development, strengthen supervision, and build industry standards to promote innovation in nuclear medicine products and the healthy development of the industry.

Speech by Li Hua, Deputy Director of the Sichuan Provincial Drug Administration

During the keynote speech session, Professors Zhang Liyuan, Tian Rong, and Wang Li respectively delivered keynote reports on the cutting-edge technology of nuclear medicine leading health transformation, the development report of nuclear medicine in Sichuan Province, and the innovative research and development and transfer pathways of nuclear pharmaceuticals. In the thematic sharing session, Zhang Wei, Director of the Department of Nuclear Medicine at Sichuan Provincial People's Hospital, Jiang Xiao, Ph.D. from Sichuan Cancer Hospital, and Zhou Yan, Director of the Laboratory at Mianyang Central Hospital, respectively introduced the development journey of nuclear medicine departments.

He Xintan, General Manager of Zhongjiu Flashlight Medical Technology Co., Ltd., also delivered an exciting presentation:

As a leader in the field of Flash radiotherapy technology, Zhongjiu Flashlight is gradually changing the future of traditional radiotherapy through its forward-looking technological innovation and relentless efforts.

General Manager He Xintan focused on the significant advantages of Flash technology: the ultra-high dose rate treatment not only dramatically shortens the treatment course but also significantly reduces side effects for patients. He detailed the journey of Flash radiotherapy technology from laboratory research to clinical application, especially the progress made in human trials of electron and proton Flash technologies.

It is worth noting that Zhongjiu Flashlight has achieved a major breakthrough in the development of Flash equipment. The company has successfully developed the first domestic e-Flash200A device and an X-ray Flash radiotherapy device. These innovative achievements not only demonstrate the company's leading position in technology but also lay a solid foundation for the popularization and application of Flash radiotherapy technology.

In addition, General Manager He Xintan shared the company's comprehensive support for promoting Flash research and clinical trials. Zhongjiu Flashlight has invested heavily in laboratory construction and animal experiment facilities and provides researchers with full technical and resource support. The aim is to accelerate the development and application of Flash radiotherapy technology in China, benefiting more patients.

Report by He Xintan, General Manager of Zhongjiu Flashlight Company

During the meeting, a roundtable forum was held, with lively discussions on "Exploring Innovative Development Paths for Sichuan's Unique Nuclear Medicine Industry."

Roundtable Forum Discussion Session

Concurrently with the meeting, the Sichuan Nuclear Medicine Industry Innovation Achievement Exhibition was held. Key nuclear medicine departments of medical and health institutions, pharmaceutical companies, and industrial parks within the province participated in the exhibition, showcasing the vibrant innovation of the province's nuclear medicine industry.

At the Sichuan Nuclear Medicine Industry Innovation Achievement Exhibition

Participants included leaders and relevant staff from the Department of Science and Education, Department of Pharmaceutical and Food, Department of System Reform and Policy Research, Department of International Cooperation, Sichuan Medical Science and Education Center, and the Center for Aging Health of the Health Commission of Sichuan Province. Also attending were leaders in charge of tertiary hospitals, heads of science and technology departments, and nuclear medicine departments (radiology departments) across the province, as well as leaders and staff from medical and health industrial parks, health-related associations (academic societies), and pharmaceutical technology companies.